| 1 |
35327426 | Different HSP90 Inhibitors Exert Divergent Effect on Myxoid Liposarcoma In Vitro and In Vivo. | 2022 Mar 7 |
1 |
| 2 |
34199261 | The HSP90 Inhibitor, AUY-922, Protects and Repairs Human Lung Microvascular Endothelial Cells from Hydrochloric Acid-Induced Endothelial Barrier Dysfunction. | 2021 Jun 13 |
2 |
| 3 |
28797845 | The HSP90 inhibitor, NVP-AUY922, attenuates intrinsic PI3K inhibitor resistance in KRAS-mutant non-small cell lung cancer. | 2017 Oct 10 |
1 |
| 4 |
26723875 | The HSP90 inhibitor, NVP-AUY922, sensitizes KRAS-mutant non-small cell lung cancer with intrinsic resistance to MEK inhibitor, trametinib. | 2016 Mar 1 |
1 |
| 5 |
27391062 | Reactivation of ERK and Akt confers resistance of mutant BRAF colon cancer cells to the HSP90 inhibitor AUY922. | 2016 Aug 2 |
2 |
| 6 |
26225840 | Hsp90 inhibition by AUY922 as an effective treatment strategy against myxoid liposarcoma. | 2015 Oct 28 |
1 |